XML 90 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Jun. 26, 2013
Jun. 27, 2012
Cash flows from operating activities:    
Net income $ 13,279 $ 10,466
Adjustments to reconcile net income to cash flows provided by operating activities:    
Depreciation and amortization 10,576 11,887
Operating (gains), losses and other charges, net 1,618 (4,174)
Amortization of deferred financing costs 256 503
Amortization of debt discount 0 137
Loss on early extinguishment of debt 1,687 8,152
(Gain) loss on change in the fair value of interest rate caps (36) 41
Deferred income tax expense 4,876 6,349
Share-based compensation 2,381 1,666
Decrease (increase) in assets:    
Receivables 1,986 791
Inventories 52 471
Other current assets 3,718 5,697
Other assets (1,105) (2,046)
Increase (decrease) in liabilities:    
Accounts payable (2,734) (5,781)
Accrued salaries and vacations (4,783) (361)
Accrued taxes 360 (135)
Other accrued liabilities (3,930) (4,917)
Other noncurrent liabilities and deferred credits (3,879) (2,518)
Net cash flows provided by operating activities 24,322 26,228
Cash flows from investing activities:    
Purchase of property (7,745) (4,279)
Acquisition of restaurant (799) 0
Proceeds from disposition of property 22 12,929
Collections on notes receivable 2,407 1,490
Issuance of notes receivable (757) (1,124)
Net cash flows (used in) provided by investing activities (6,872) 9,016
Cash flows from financing activities:    
Net revolver borrowings under new credit agreement 97,500 0
Term loan borrowings under new credit agreement 60,000 190,000
Long-term debt payments (172,936) (207,407)
Proceeds from exercise of stock options 1,225 649
Tax withholding on share-based payments (464) (145)
Tax (expense) benefit of stock options exercised (172) 58
Debt transaction costs (366) (1,095)
Deferred financing costs (1,314) (1,809)
Purchase of treasury stock (10,751) (5,470)
Net bank overdrafts (1,726) (2,768)
Net cash flows used in financing activities (29,004) (27,987)
(Decrease) increase in cash and cash equivalents (11,554) 7,257
Cash and cash equivalents at beginning of period 13,565 13,740
Cash and cash equivalents at end of period $ 2,011 $ 20,997